#United States #Birmingham, Alabama #Streamline Scientific #UTI Testing #Antibiotic Stewardship

Streamline Scientific Introduces Enhanced PCR Reporting Service for UTIs

Streamline Scientific, a leader in molecular testing and intelligent reporting services, has made a significant advancement in the fight against urinary tract infections (UTIs). The company announced today the launch of its enhanced PCR reporting service, tailored specifically to improve treatment decisions and promote responsible antibiotic prescribing.

Every year, over 10 million doctor visits in the United States are attributed to UTIs. Alarmingly, in many instances, antibiotics are administered even before laboratory test results are available. Research indicates that nearly 30% of these prescriptions may not be suitable, leading not only to prolonged recovery times for patients but also contributing to the escalating problem of antimicrobial resistance. Recognizing the urgent need for improved patient outcomes, Streamline Scientific's new reporting service weaves the Clinical and Laboratory Standards Institute (CLSI) M100 guidelines directly into PCR results, delivering robust insights on the pathogens involved and their associated resistance markers.

The CLSI M100 guidelines represent the gold standard in industry practices for microbiology culture and sensitivity testing related to UTIs. The CLSI M100 subcommittee's goal is to provide clinicians with valuable information that assists in selecting the right antimicrobial therapy for optimal patient care.

Addressing the Challenge of Antibiotic Stewardship

Shawn Hood, president of Streamline Scientific, highlighted the critical role of antibiotic stewardship in contemporary healthcare. He stated, "Antibiotic stewardship is one of the most pressing challenges in healthcare today, and UTIs are a major contributor to inappropriate prescribing. Our enhanced PCR reporting service bridges the gap between lab results and treatment decisions, giving providers clearer insights based on the best available guidelines. It's a cost-effective way to improve care while helping labs deliver greater value to their clients."

The newly enhanced reporting format is designed for usability, ensuring that physicians can easily connect lab results with established clinical guidelines. Instead of relying on raw PCR results that can be ambiguous, healthcare providers will receive reports that effectively link specific pathogens to relevant resistance markers and treatment recommendations based on CLSI protocols. For instance, if a report indicates the presence of E. coli resistant to sulfonamides or trimethoprim, the report will flag these medications as ineffective and recommend better-supported alternatives.

This process results in faster and more confident prescribing, ultimately benefiting patient care while promoting better antibiotic stewardship across healthcare practices.

A Win-Win for Labs and Medical Practices

The development of this service was undertaken with both laboratories and healthcare providers in mind. For laboratories, it offers a competitive edge in a saturated marketplace, adding clinical value without necessitating new equipment investments. Meanwhile, physicians gain access to reports that demystify complex PCR data, making the information actionable and simplifying the alignment with stewardship objectives.

Furthermore, the service’s foundation on existing PCR workflows enables rapid implementation, negating the need for extensive new hardware or software platforms.

For additional insights related to this revolutionary PCR reporting service from Streamline Scientific, interested parties can visit their website at www.streamlinesci.com/reporting.

About Streamline Scientific

Streamline Scientific comprises a dedicated team of medical professionals and scientists aimed at simplifying the application of molecular technologies to enhance the value of infectious disease diagnostics. With CLIA-certified reference laboratories located in Alabama and Texas, Streamline Scientific excels in delivering advanced molecular testing services and intelligent reporting solutions to support clinical decision-making and improve antibiotic stewardship. Learn more at www.streamlinesci.com.